These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 21872356)

  • 1. Abnormality of the hepatocyte growth factor/MET pathway in pulmonary adenocarcinogenesis.
    Tachibana K; Minami Y; Shiba-Ishii A; Kano J; Nakazato Y; Sato Y; Goya T; Noguchi M
    Lung Cancer; 2012 Feb; 75(2):181-8. PubMed ID: 21872356
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MET amplification, protein expression, and mutations in pulmonary adenocarcinoma.
    Park S; Koh J; Kim DW; Kim M; Keam B; Kim TM; Jeon YK; Chung DH; Heo DS
    Lung Cancer; 2015 Dec; 90(3):381-7. PubMed ID: 26791796
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression of ezrin, HGF and c-met and its clinicopathological significance in the benign and malignant lesions of the gallbladder.
    Yang L; Guo T; Jiang S; Yang Z
    Hepatogastroenterology; 2012 Sep; 59(118):1769-75. PubMed ID: 22172411
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Concurrent MET copy number gain and KRAS mutation is a poor prognostic factor in pancreatobiliary subtype ampullary cancers.
    Kwon MJ; Kim JW; Jeon JY; Nam ES; Cho SJ; Park HR; Min SK; Seo J; Min KW; Choe JY; Lee HK
    Pathol Res Pract; 2017 Apr; 213(4):381-388. PubMed ID: 28214200
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High MET gene copy number leads to shorter survival in patients with non-small cell lung cancer.
    Go H; Jeon YK; Park HJ; Sung SW; Seo JW; Chung DH
    J Thorac Oncol; 2010 Mar; 5(3):305-13. PubMed ID: 20107422
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comprehensive molecular analyses of lung adenocarcinoma with regard to the epidermal growth factor receptor, K-ras, MET, and hepatocyte growth factor status.
    Onitsuka T; Uramoto H; Ono K; Takenoyama M; Hanagiri T; Oyama T; Izumi H; Kohno K; Yasumoto K
    J Thorac Oncol; 2010 May; 5(5):591-6. PubMed ID: 20150826
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Alterations of MET Gene Copy Number and Protein Expression in Primary Non-Small-Cell Lung Cancer and Corresponding Nodal Metastases.
    Tran TN; Selinger CI; Kohonen-Corish MR; McCaughan B; Kennedy C; O'Toole SA; Cooper WA
    Clin Lung Cancer; 2016 Jan; 17(1):30-8.e1. PubMed ID: 26395411
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hepatocyte growth factor production by neutrophils infiltrating bronchioloalveolar subtype pulmonary adenocarcinoma: role in tumor progression and death.
    Wislez M; Rabbe N; Marchal J; Milleron B; Crestani B; Mayaud C; Antoine M; Soler P; Cadranel J
    Cancer Res; 2003 Mar; 63(6):1405-12. PubMed ID: 12649206
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hepatocyte growth factor and c-Met/hepatocyte growth factor receptor in pulmonary adenocarcinomas: an evaluation of their expression as prognostic markers.
    Takanami I; Tanana F; Hashizume T; Kikuchi K; Yamamoto Y; Yamamoto T; Kodaira S
    Oncology; 1996; 53(5):392-7. PubMed ID: 8784474
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tumor angiogenesis, hepatocyte growth factor, and c-Met expression in endometrial carcinoma.
    Wagatsuma S; Konno R; Sato S; Yajima A
    Cancer; 1998 Feb; 82(3):520-30. PubMed ID: 9452270
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Co-existence of positive MET FISH status with EGFR mutations signifies poor prognosis in lung adenocarcinoma patients.
    Tanaka A; Sueoka-Aragane N; Nakamura T; Takeda Y; Mitsuoka M; Yamasaki F; Hayashi S; Sueoka E; Kimura S
    Lung Cancer; 2012 Jan; 75(1):89-94. PubMed ID: 21733594
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Frequent hepatocyte growth factor overexpression and low frequency of c-Met gene amplification in human papillomavirus-negative tonsillar squamous cell carcinoma and their prognostic significances.
    Kwon MJ; Kim DH; Park HR; Shin HS; Kwon JH; Lee DJ; Kim JH; Cho SJ; Nam ES
    Hum Pathol; 2014 Jul; 45(7):1327-38. PubMed ID: 24810547
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hepatocyte growth factor and Met/HGF receptors in patients with gastric adenocarcinoma.
    Wu CW; Li AF; Chi CW; Chung WW; Liu TY; Lui WY; P'eng FK
    Oncol Rep; 1998; 5(4):817-22. PubMed ID: 9625824
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Protein overexpression and gene amplification of cellular mesenchymal-epithelial transition factor is associated with poor prognosis in micropapillary-predominant subtype pulmonary adenocarcinoma.
    Zhang J; Sun J; Zhang Z; Liang X; Luo Y; Wu S; Liang Z
    Hum Pathol; 2018 Feb; 72():59-65. PubMed ID: 29128478
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression of hepatocyte growth factor and c-met protein is significantly associated with the progression of oral squamous cell carcinoma in Taiwan.
    Chen YS; Wang JT; Chang YF; Liu BY; Wang YP; Sun A; Chiang CP
    J Oral Pathol Med; 2004 Apr; 33(4):209-17. PubMed ID: 15061708
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hepatocyte growth factor/scatter factor and its receptor c-Met are overexpressed and associated with an increased microvessel density in malignant pleural mesothelioma.
    Tolnay E; Kuhnen C; Wiethege T; König JE; Voss B; Müller KM
    J Cancer Res Clin Oncol; 1998; 124(6):291-6. PubMed ID: 9692834
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MET gene copy number gain is an independent poor prognostic marker in Korean stage I lung adenocarcinomas.
    Jin Y; Sun PL; Kim H; Seo AN; Jheon S; Lee CT; Chung JH
    Ann Surg Oncol; 2014 Feb; 21(2):621-8. PubMed ID: 24212721
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High MET receptor expression but not gene amplification in ALK 2p23 rearrangement positive non-small-cell lung cancer.
    Feng Y; Minca EC; Lanigan C; Liu A; Zhang W; Yin L; Pennell NA; Farver C; Tubbs R; Ma PC
    J Thorac Oncol; 2014 May; 9(5):646-53. PubMed ID: 24722154
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Activation of hepatocyte growth factor-met autocrine loop enhances tumorigenicity in a human lung adenocarcinoma cell line.
    Yi S; Tsao MS
    Neoplasia; 2000; 2(3):226-34. PubMed ID: 10935508
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High MET copy number and MET overexpression: poor outcome in non-small cell lung cancer patients.
    Park S; Choi YL; Sung CO; An J; Seo J; Ahn MJ; Ahn JS; Park K; Shin YK; Erkin OC; Song K; Kim J; Shim YM; Han J
    Histol Histopathol; 2012 Feb; 27(2):197-207. PubMed ID: 22207554
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.